Senate Special Committee on Aging

The Senate Special Committee on Aging is a U.S. Senate committee that focuses on issues affecting older Americans. While it lacks legislative authority, it plays a crucial role in investigating problems, conducting oversight, and making recommendations to other Senate committees and government agencies. The committee is currently newsworthy due to its focus on the pharmaceutical industry, particularly regarding the transparency and security of generic drug manufacturing. Recent events include a hearing where committee members criticized manufacturers for concealing drugmaking locations and the introduction of the 'Clear Labels Act,' which would require prescription drug labels to identify the country of origin. This activity highlights the committee's concern about the overreliance on foreign drug manufacturers and the potential risks to national security and public health. The committee's work is relevant as it seeks to improve transparency and potentially incentivize domestic drug production, addressing concerns about drug safety, supply chain vulnerabilities, and economic competitiveness.